{"items":[{"title":"Revita Reduces Weight Regain After GLP-1 Discontinuation in REMAIN-1 - HCPLive","date":"October 16, 2026","summary":"Revita Reduces Weight Regain After GLP-1 Discontinuation in REMAIN-1","href":"https://www.hcplive.com/view/revita-reduces-weight-regain-after-glp-1-discontinuation-in-remain-1","imageUrl":"https://cdn.sanity.io/images/0vv8moc6/hcplive/995112dc09c4428ba6193ea144d77afe0bc029c3-1200x630.png","imageLabel":"HCPLive","articlePreview":[]},{"title":"DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal - Yahoo Finance","date":"October 16, 2026","summary":"DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal","href":"https://finance.yahoo.com/healthcare/articles/datameds-ai-plans-peptide-compounding-105607076.html","imageUrl":"https://s.yimg.com/eo/images/347aaaafea52bb4acdd656237d94a6818bd79750218634d4294e992da3c3e373.png","imageLabel":"Yahoo Finance","articlePreview":[]},{"title":"AI antimicrobial peptide discovery: DeepMind’s lead - NeoTeo","date":"October 16, 2026","summary":"AI antimicrobial peptide discovery: DeepMind’s lead","href":"https://www.neoteo.com/en/google-deepminds-ai-peptide-candidate-is-undergoing-lab-validation","imageUrl":"https://www.neoteo.com/image_resizer/1178313/w/1376/h/774/resize/post_hero.webp","imageLabel":"NeoTeo","articlePreview":[]},{"title":"Many 'Branded' GLP-1 Users on Compounded Drugs, Photos Show - Medscape","date":"October 16, 2026","summary":"Many 'Branded' GLP-1 Users on Compounded Drugs, Photos Show","href":"https://www.medscape.com/viewarticle/many-branded-glp-1-users-compounded-drugs-photos-show-2026a10012wl","imageUrl":"https://www.medscape.com/u002F/u002Fimg.medscapestatic.com/u002Fvim/u002Flive/u002Fprofessional_assets/u002Fmedscape/u002Fimages/u002Fthumbnail_library/u002Fgty-260114-semaglutide-glp-1-800x450.jpg","imageLabel":"Medscape","articlePreview":[]},{"title":"What do GLP-1 users want to eat and drink when they’re out? - FoodNavigator.com","date":"October 16, 2026","summary":"What do GLP-1 users want to eat and drink when they’re out?","href":"https://www.foodnavigator.com/Article/2026/10/16/the-glp-1-diner-is-changing-the-menu/","imageUrl":"https://cloudfront-eu-central-1.images.arcpublishing.com/williamreed/4LY3TXMJO5GLNCFXOBTC3AVS5Q.jpg","imageLabel":"FoodNavigator.com","articlePreview":[]},{"title":"US FDA takes step to change peptide compounding policy - pharma.economictimes.indiatimes.com","date":"October 16, 2026","summary":"US FDA takes step to change peptide compounding policy","href":"https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/us-fda-takes-step-to-change-peptide-compounding-policy/134984911","imageUrl":"https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/us-fda-takes-step-to-change-peptide-compounding-policy/resize_mode-2/files/data_file_17568132097802_30403.jpg","imageLabel":"pharma.economictimes.indiatimes.com","articlePreview":[]},{"title":"Why your health insurance is dropping GLP-1 coverage - Vox","date":"October 15, 2026","summary":"Why your health insurance is dropping GLP-1 coverage","href":"https://www.vox.com/good-medicine-newsletter/506555/glp-1-wegovy-zepbound-cost-health-insurance","imageUrl":"https://platform.vox.com/wp-content/uploads/sites/2/2026/10/GettyImages-2270066907.jpg?quality=90&strip=all","imageLabel":"Vox","articlePreview":[]},{"title":"New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides - News-Medical","date":"October 14, 2026","summary":"New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides","href":"https://www.news-medical.net/news/20261014/New-project-receives-2423-million-to-develop-a-database-and-AI-model-to-identify-therapeutic-peptides.aspx","imageUrl":"https://www.news-medical.net/image-handler/picture/2019/5/science%2c_chemistry%2c_biology%2c_medicine_and_people_concept_-_close_up_of_young_fem_-_Syda_Productions_M1_1e674058e745483caa7a7d4ed53e4396-125x110.jpg","imageLabel":"News-Medical","articlePreview":[]},{"title":"PTGX - Royalty-Funded Pipeline Expansion Will Drive Long-Term Value From Oral Peptide Programs - Simply Wall Street","date":"October 14, 2026","summary":"PTGX - Royalty-Funded Pipeline Expansion Will Drive Long-Term Value From Oral Peptide Programs","href":"https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-ptgx/protagonist-therapeutics/1kvkczxp-royalty-funded-pipeline-expansion-will-drive-long-term-value-from-oral-peptide-programs?bpId=4790750&link_type=cta_narrative_prompt_after_quote","imageUrl":"https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-ptgx/protagonist-therapeutics/metadata=none/https://images.simplywall.st/asset/user/6236d9ff.1744096362358.09df9a35fe37bf47.jpg","imageLabel":"Simply Wall Street","articlePreview":[]}],"heroItems":[{"title":"Revita Reduces Weight Regain After GLP-1 Discontinuation in REMAIN-1 - HCPLive","date":"October 16, 2026","summary":"Revita Reduces Weight Regain After GLP-1 Discontinuation in REMAIN-1","href":"https://www.hcplive.com/view/revita-reduces-weight-regain-after-glp-1-discontinuation-in-remain-1","imageUrl":"https://cdn.sanity.io/images/0vv8moc6/hcplive/995112dc09c4428ba6193ea144d77afe0bc029c3-1200x630.png","imageLabel":"HCPLive","articlePreview":[]},{"title":"DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal - Yahoo Finance","date":"October 16, 2026","summary":"DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal","href":"https://finance.yahoo.com/healthcare/articles/datameds-ai-plans-peptide-compounding-105607076.html","imageUrl":"https://s.yimg.com/eo/images/347aaaafea52bb4acdd656237d94a6818bd79750218634d4294e992da3c3e373.png","imageLabel":"Yahoo Finance","articlePreview":[]},{"title":"AI antimicrobial peptide discovery: DeepMind’s lead - NeoTeo","date":"October 16, 2026","summary":"AI antimicrobial peptide discovery: DeepMind’s lead","href":"https://www.neoteo.com/en/google-deepminds-ai-peptide-candidate-is-undergoing-lab-validation","imageUrl":"https://www.neoteo.com/image_resizer/1178313/w/1376/h/774/resize/post_hero.webp","imageLabel":"NeoTeo","articlePreview":[]},{"title":"Many 'Branded' GLP-1 Users on Compounded Drugs, Photos Show - Medscape","date":"October 16, 2026","summary":"Many 'Branded' GLP-1 Users on Compounded Drugs, Photos Show","href":"https://www.medscape.com/viewarticle/many-branded-glp-1-users-compounded-drugs-photos-show-2026a10012wl","imageUrl":"https://www.medscape.com/u002F/u002Fimg.medscapestatic.com/u002Fvim/u002Flive/u002Fprofessional_assets/u002Fmedscape/u002Fimages/u002Fthumbnail_library/u002Fgty-260114-semaglutide-glp-1-800x450.jpg","imageLabel":"Medscape","articlePreview":[]},{"title":"What do GLP-1 users want to eat and drink when they’re out? - FoodNavigator.com","date":"October 16, 2026","summary":"What do GLP-1 users want to eat and drink when they’re out?","href":"https://www.foodnavigator.com/Article/2026/10/16/the-glp-1-diner-is-changing-the-menu/","imageUrl":"https://cloudfront-eu-central-1.images.arcpublishing.com/williamreed/4LY3TXMJO5GLNCFXOBTC3AVS5Q.jpg","imageLabel":"FoodNavigator.com","articlePreview":[]},{"title":"US FDA takes step to change peptide compounding policy - pharma.economictimes.indiatimes.com","date":"October 16, 2026","summary":"US FDA takes step to change peptide compounding policy","href":"https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/us-fda-takes-step-to-change-peptide-compounding-policy/134984911","imageUrl":"https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/us-fda-takes-step-to-change-peptide-compounding-policy/resize_mode-2/files/data_file_17568132097802_30403.jpg","imageLabel":"pharma.economictimes.indiatimes.com","articlePreview":[]},{"title":"Why your health insurance is dropping GLP-1 coverage - Vox","date":"October 15, 2026","summary":"Why your health insurance is dropping GLP-1 coverage","href":"https://www.vox.com/good-medicine-newsletter/506555/glp-1-wegovy-zepbound-cost-health-insurance","imageUrl":"https://platform.vox.com/wp-content/uploads/sites/2/2026/10/GettyImages-2270066907.jpg?quality=90&strip=all","imageLabel":"Vox","articlePreview":[]},{"title":"New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides - News-Medical","date":"October 14, 2026","summary":"New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides","href":"https://www.news-medical.net/news/20261014/New-project-receives-2423-million-to-develop-a-database-and-AI-model-to-identify-therapeutic-peptides.aspx","imageUrl":"https://www.news-medical.net/image-handler/picture/2019/5/science%2c_chemistry%2c_biology%2c_medicine_and_people_concept_-_close_up_of_young_fem_-_Syda_Productions_M1_1e674058e745483caa7a7d4ed53e4396-125x110.jpg","imageLabel":"News-Medical","articlePreview":[]},{"title":"PTGX - Royalty-Funded Pipeline Expansion Will Drive Long-Term Value From Oral Peptide Programs - Simply Wall Street","date":"October 14, 2026","summary":"PTGX - Royalty-Funded Pipeline Expansion Will Drive Long-Term Value From Oral Peptide Programs","href":"https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-ptgx/protagonist-therapeutics/1kvkczxp-royalty-funded-pipeline-expansion-will-drive-long-term-value-from-oral-peptide-programs?bpId=4790750&link_type=cta_narrative_prompt_after_quote","imageUrl":"https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-ptgx/protagonist-therapeutics/metadata=none/https://images.simplywall.st/asset/user/6236d9ff.1744096362358.09df9a35fe37bf47.jpg","imageLabel":"Simply Wall Street","articlePreview":[]}],"tickerItems":[{"tag":"GLP-1 Watch","text":"Inside Teva's Weltruza launch and Novo's GLP-1 strategy - Fierce Pharma","href":"https://www.fiercepharma.com/pharma/inside-tevas-weltruza-launch-and-novos-glp-1-strategy","source":"Fierce Pharma","date":"October 16, 2026"},{"tag":"Compounding Watch","text":"DataMeds outlines peptide compounding plans after FDA policy proposal - StreetInsider","href":"https://www.streetinsider.com/Corporate+News/DataMeds+outlines+peptide+compounding+plans+after+FDA+policy+proposal/27195249.html","source":"StreetInsider","date":"October 16, 2026"},{"tag":"GLP-1 Watch","text":"The Difficulty of Diagnosing Anorexia in the GLP-1 Era - The New York Times","href":"https://www.nytimes.com/2026/10/16/well/glp1-anorexia-eating-disorders.html","source":"The New York Times","date":"October 16, 2026"},{"tag":"Drug Discovery","text":"Scientists Thought This Peptide Was Harmless. A New Discovery Could Rewrite Alzheimer’s Research - Inc.com","href":"https://www.inc.com/lucia-auerbach/alzheimers-research-peptide-breakthrough-p3-amyloid-alpha/91420545","source":"Inc.com","date":"October 15, 2026"},{"tag":"Drug Discovery","text":"Google DeepMind Walkthrough Details Antimicrobial Peptide Discovery - Unite.AI","href":"https://www.unite.ai/google-deepmind-walkthrough-details-antimicrobial-peptide-discovery/","source":"Unite.AI","date":"October 15, 2026"},{"tag":"Antimicrobial Peptides","text":"Accelerating the search for antimicrobial peptides with Google Antigravity - Google DeepMind","href":"https://deepmind.google/blog/accelerating-antimicrobial-discovery/","source":"Google DeepMind","date":"October 15, 2026"},{"tag":"Compounding Watch","text":"FDA Peptide Compounding Policy: What a Temporary Enforcement Reprieve Could Mean for Pharmacies - Buchanan Ingersoll & Rooney PC","href":"https://www.bipc.com/fda-peptide-compounding-policy-what-a-temporary-enforcement-reprive-could-mean-for-pharmacies","source":"Buchanan Ingersoll & Rooney PC","date":"October 14, 2026"},{"tag":"GLP-1 Watch","text":"Could GLP-1 drugs be anti-aging medications? - CNN","href":"https://www.cnn.com/2026/10/13/health/glp-1-drugs-anti-aging","source":"CNN","date":"October 13, 2026"},{"tag":"Antimicrobial Peptides","text":"A Salmonella -specific protein enhances the antimicrobial peptide response of the PhoPQ two-component system - ASM Journals","href":"https://journals.asm.org/doi/10.1128/mbio.01070-26","source":"ASM Journals","date":"October 9, 2026"},{"tag":"Delivery Tech","text":"FibroBiologics files patent for cell-based peptide delivery - Investing.com","href":"https://www.investing.com/news/company-news/fibrobiologics-files-patent-for-cellbased-peptide-delivery-93CH-4936686","source":"Investing.com","date":"October 7, 2026"},{"tag":"Legal Watch","text":"Advisory Committee Calendar - U.S. Food and Drug Administration (.gov)","href":"https://www.fda.gov/advisory-committees/advisory-committee-calendar","source":"U.S. Food and Drug Administration (.gov)","date":"October 1, 2026"},{"tag":"Peptide Therapeutics","text":"Peptide Therapeutics Market Size, Industry Share, Forecast, 2034 - Fortune Business Insights","href":"https://www.fortunebusinessinsights.com/industry-reports/peptide-therapeutics-market-101420","source":"Fortune Business Insights","date":"September 28, 2026"},{"tag":"Compounding Watch","text":"Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote - The American Journal of Managed Care","href":"https://www.ajmc.com/view/peptide-regulation-debate-intensifies-after-fda-advisory-panel-s-controversial-vote","source":"The American Journal of Managed Care","date":"September 25, 2026"},{"tag":"GLP-1 Watch","text":"FDA Warns Pharmacy About Illegal GLP-1 Compounding - MedPage Today","href":"https://www.medpagetoday.com/publichealthpolicy/fdageneral/123122","source":"MedPage Today","date":"September 23, 2026"},{"tag":"GLP-1 Watch","text":"GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds - Contemporary Pediatrics","href":"https://www.contemporarypediatrics.com/view/glp-1-receptor-agonists-tied-to-nutritional-deficiencies-in-children-study-finds","source":"Contemporary Pediatrics","date":"September 23, 2026"},{"tag":"GLP-1 Watch","text":"McDonald's is exploring ways to attract GLP-1 users - Axios","href":"https://www.axios.com/2026/09/23/mcdonalds-glp-1-bowls-grilled-chicken","source":"Axios","date":"September 23, 2026"},{"tag":"Peptide Therapeutics","text":"Screening therapeutic peptides for ‘undruggable’ proteins - Chemistry World","href":"https://www.chemistryworld.com/news/screening-therapeutic-peptides-for-undruggable-proteins/4024242.article","source":"Chemistry World","date":"September 23, 2026"},{"tag":"Legal Watch","text":"Empower Clinic Services, LLC dba Empower Pharmacy - 738238 - 09/18/2026 - fda.gov","href":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026","source":"fda.gov","date":"September 18, 2026"},{"tag":"Drug Discovery","text":"Harnessing snake venom cardiotoxins for antimicrobial peptide discovery - Nature","href":"https://www.nature.com/articles/s44386-026-00073-2?error=cookies_not_supported&code=2cf02f7d-1b14-4e6c-9175-1cb2847c76b9","source":"Nature","date":"September 16, 2026"},{"tag":"Safety Watch","text":"Are Peptides Safe? Potential Risks to Consider - GoodRx","href":"https://www.goodrx.com/health-topic/peptides/are-peptides-safe","source":"GoodRx","date":"September 16, 2026"},{"tag":"Peptide Therapeutics","text":"TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate - SynBioBeta","href":"https://www.synbiobeta.com/read/twostep-therapeutics-announces-oversubscribed-62.5-million-series-a-financing-and-fda-clearance-of-ind-for-first-in-class-peptide-drug-conjugate","source":"SynBioBeta","date":"September 15, 2026"},{"tag":"Delivery Tech","text":"BioLife Secures U.S. Patent for First-of-its-kind Effervescent Oral Peptide Delivery Technology - New Castle News","href":"https://www.ncnewsonline.com/news/national/biolife-secures-u-s-patent-for-first-of-its-kind-effervescent-oral-peptide-delivery-technology/article_e556adc7-fd39-5b12-a6e9-98bde3886cc1.html","source":"New Castle News","date":"September 10, 2026"},{"tag":"Delivery Tech","text":"BioLife patents effervescent oral peptide delivery platform targeting GLP-1 therapies - Drug Target Review","href":"https://www.drugtargetreview.com/news/biolife-patents-effervescent-oral-peptide-delivery-platform-targeting-glp-1-therapies/2136442.article","source":"Drug Target Review","date":"September 10, 2026"},{"tag":"Delivery Tech","text":"BioLife Secures U.S. Patent for First-of-its-kind Effervescent Oral Peptide Delivery Technology - Business Wire","href":"https://www.businesswire.com/news/home/20260910717829/en/BioLife-Secures-U.S.-Patent-for-First-of-its-kind-Effervescent-Oral-Peptide-Delivery-Technology","source":"Business Wire","date":"September 10, 2026"}]}